Mode
Home
Research
Clinical Trials Drug Pipeline Weekly Digests
Reference
Conditions Medications
Community
Questions
Text Size
Log in / Sign up
Home › Medications › bimatoprost

bimatoprost

2 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials of bimatoprost

10 trials tracked of bimatoprost: 2 in phase 3 or 4.

10Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 7 Other / NA 1
  1. Phase 4 The Effects of Xalatan, Travatan and Lumigan on Skin Pigmentation Near the Eye Completed
  2. Phase 3 Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients Completed
  3. Phase 2 Bimatoprost Ocular Insert Compared to Topical Timolol Solution in Patients With Glaucoma or Ocular Hypertension Completed
  4. Phase 2 A Study to Evaluate Efficacy and Safety of a Fixed Combination Ocular Insert in Participants With Open-angle Glaucoma or Ocular Hypertension Completed
  5. Phase 2 Dose-Ranging Study of the Bimatoprost Ocular Insert Completed
  6. Phase 2 Topical Bimatoprost Effect on Androgen Dependent Hair Follicles Completed
Show 4 more trials
  1. Phase 2 An Open-label Extension Study to Evaluate the Safety of the 13 mg Bimatoprost Ocular Insert Completed
  2. Phase 2 Safety and Efficacy of AGN-210669 Ophthalmic Solution Compared With Bimatoprost Ophthalmic Solution in Patients With Open-Angle Glaucoma or Ocular Hypertension Completed
  3. Phase 2 An Open-Label Extension Study to Evaluate the Safety of the ForSight VISION5 Product Completed
  4. N/A A Study Comparing IOP-Lowering Treatments to Bimatoprost in Patients With Primary Open Angle Glaucoma or Ocular Hypertension Completed

Showing the 10 most-cited and recently-updated of 10 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations
Ophthalmology Sys. Review
Preservative Free Bimatoprost 0.01% Shows Non Inferiority to Higher Concentration Formulations Preservative-free bimatoprost shows similar results for glaucoma eye pressure
Preservative-free bimatoprost 0.01% provides comparable intraocular pressure reduction to higher concentrations with improved local tolerabi…
A new look at eye drops shows that preservative-free bimatoprost lowers eye pressure as well as stronger versions with fewer side effects.
Sep 4, 2026
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues
Ophthalmology Meta-analysis
Netarsudil shows lower IOP reduction but better conjunctival hyperemia profile versus prostaglandin analogues New data shows netarsudil offers a safer option for some glaucoma patients
A Bayesian network meta-analysis found netarsudil ranked lower for IOP reduction but had a more favorable conjunctival hyperemia profile com…
A fresh look at glaucoma drugs shows one option causes less redness while still helping lower eye pressure effectively.
May 14, 2026